Related Experiment Video
Updated: Jan 14, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Sustained A1c Reduction Facilitated by Minimally Time-Consuming, Ongoing Outcome Assessments and Guided Interventions
Xin Zhang1, Tiaha E McGettigan1
1Division of Pharmacy, Reedsburg Area Medical Center, Reedsburg, WI, USA.
Abstract:
PurposeTo evaluate the effect and sustainability of A1c reduction in a rural diabetes education program that integrates minimally time-consuming, ongoing outcome assessments and interventions guided by these assessments.DesignRetrospective pre-post studies in monthly cohorts.SettingA clinic in rural Wisconsin.SubjectsIndividuals with type 1 or type 2 diabetes who completed initial program visits between October 2023 and March 2024 (n = 86; monthly cohort sizes ranged from 10 to 18).InterventionA diabetes education program that incorporates minimally time-consuming, ongoing outcome assessments and guided interventions.MeasuresBaseline A1c values and the most recent A1c values by the end of months 7 and 13.AnalysisAt the practice level, average A1c reductions were calculated for each monthly cohort, and paired t-tests were used to assess statistical significance. At the individual level, A1c values were plotted to guide interventions.ResultsAll 6 monthly cohorts showed average A1c reductions between 1.0% and 2.4% at both the 7- and 13-month time points. Most reductions were statistically significant. Interventions guided by individual-level assessments appeared to support improved outcomes.ConclusionThis rural diabetes education program demonstrated sustained A1c improvement using practical, minimally resource-intensive outcome assessments and guided interventions. While the absence of a control group limits causal inference, this approach may offer a feasible model for chronic disease management in resource-limited settings.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Dipeptidyl Peptidase 4 Inhibitors
Diabetes: Symptoms, Diagnosis, and Complications

